Search Results for: RedHill

Positive results in Type 1 diabetes treatment study

Israel’s Redhill Biopharma announced preliminary positive data from a pre-clinical study with RHB-104 for the treatment of Type 1 diabetes. Trials of RHB-104 for treating Crohn’s disease and Multiple Sclerosis are on going and are planned for Rheumatoid Arthritis. http://online.wsj.com/article/PR-CO-20140626-905884.html

Posted in Israel's Medical Achievements | Leave a comment

Nausea drug success

Israel’s Redhill Biopharma announced success in Phase III trials of RHB-102 – a once-a-day pill for the prevention of nausea in cancer patients. Redhill now plans to apply to the US Food and Drug Administration for a pre-New Drug Application … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Pill to vanquish nausea after chemo

(Thanks to Israel21c) Israel’s RedHill Biopharma is to perform advanced clinical trials of a once-a-day drug, code-named RHB-102, to prevent nausea and vomiting – often a side effect of chemotherapy and radiation therapy for cancer. Current medication for this purpose … Continue reading

Posted in Israel's Medical Achievements | Leave a comment